LCM
IMCR icon

Legato Capital Management’s Immunocore IMCR Stock Holding History

Legato Capital Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,175
Closed -$661K – 595
2024
Q1 		$661K Buy
10,175
+2,940
+41% +$202K 0.08% 375
2023
Q4 		$494K Buy
7,235
+2,762
+62% +$144K 0.06% 419
2023
Q3 		$232K Buy
+4,473
New +$265K 0.03% 503

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Legato Capital Management's IMCR Position: Q2 2024 in Review

Legato Capital Management sold out of Immunocore (IMCR) in Q2 2024, closing a stake of 10,175 shares — an estimated $661K sold.

Legato Capital Management first reported a position in IMCR in Q3 2023 and held it in 3 quarters. The position peaked at $661K in Q1 2024. 138 funds tracked by Wall St. Rank hold IMCR as of Q2 2024.

  • Legato Capital Management reported no remaining Immunocore position as of Q2 2024 after selling out during the quarter.
  • Legato Capital Management sold 10,175 Immunocore shares in Q2 2024, an estimated $661K.
  • Legato Capital Management first reported a position in Immunocore in Q3 2023 and held it in 3 quarters.
  • Legato Capital Management's Immunocore position peaked at $661K in Q1 2024.
  • 138 funds tracked by Wall St. Rank held Immunocore as of Q2 2024.

Based on Legato Capital Management's 13F filing for Q2 2024, filed 26 Jul 2024.